Results 1 to 10 of about 1,580,164 (331)
Role of CD36 in central nervous system diseases [PDF]
CD36 is a highly glycosylated integral membrane protein that belongs to the scavenger receptor class B family and regulates the pathological progress of metabolic diseases.
Min Feng +7 more
doaj +3 more sources
Lactylation and Central Nervous System Diseases [PDF]
As the final product of glycolysis, lactate serves as an energy substrate, metabolite, and signaling molecule in various diseases and mediates lactylation, an epigenetic modification that occurs under both physiological and pathological conditions ...
Ye Chen, Dongqiong Xiao, Xihong Li
doaj +4 more sources
Copper homeostasis and cuproptosis in central nervous system diseases [PDF]
Copper (Cu), an indispensable micronutrient for the sustenance of living organisms, contributes significantly to a vast array of fundamental metabolic processes.
Zhipeng Zhu +5 more
doaj +3 more sources
Microglia lactylation in relation to central nervous system diseases [PDF]
The development of neurodegenerative diseases is closely related to the disruption of central nervous system homeostasis. Microglia, as innate immune cells, play important roles in the maintenance of central nervous system homeostasis, injury response ...
Hui Yang +7 more
doaj +3 more sources
Antibody-mediated central nervous system diseases [PDF]
Antibody-mediated central nervous system diseases are a relatively new area of clinical neuroscience with growing impact. Their recognition has challenged the dogma of the blood–brain barrier preventing antibody access into the central nervous system ...
Maria Pia Giannoccaro +2 more
doaj +4 more sources
NLRP3 inflammasome in neuroinflammation and central nervous system diseases. [PDF]
Neuroinflammation plays an important role in the pathogenesis of various central nervous system (CNS) diseases. The NLRP3 inflammasome is an important intracellular multiprotein complex composed of the innate immune receptor NLRP3, the adaptor protein ...
Xu W, Huang Y, Zhou R.
europepmc +2 more sources
The blood-brain barriers: novel nanocarriers for central nervous system diseases. [PDF]
The central nervous system (CNS) diseases are major contributors to death and disability worldwide. However, the blood–brain barrier (BBB) often prevents drugs intended for CNS diseases from effectively crossing into the brain parenchyma to deliver their
Liu J, Wang T, Dong J, Lu Y.
europepmc +2 more sources
Phosphatidylserine, inflammation, and central nervous system diseases
Phosphatidylserine (PS) is an anionic phospholipid in the eukaryotic membrane and is abundant in the brain. Accumulated studies have revealed that PS is involved in the multiple functions of the brain, such as activation of membrane signaling pathways ...
Xiaohua Ma +7 more
doaj +2 more sources
Role of Exosomes in Central Nervous System Diseases
There are many types of intercellular communication, and extracellular vesicles are one of the important forms of this. They are released by a variety of cell types, are heterogeneous, and can roughly be divided into microvesicles and exosomes according ...
Wanying Liu +12 more
doaj +2 more sources
Meningeal Lymphatics in Central Nervous System Diseases. [PDF]
Since its recent discovery, the meningeal lymphatic system has reshaped our understanding of central nervous system (CNS) fluid exchange, waste clearance, immune cell trafficking, and immune privilege.
Salvador AFM, Abduljawad N, Kipnis J.
europepmc +2 more sources

